Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neoprobe raises money for Lymphoseek development:

This article was originally published in Clinica

Executive Summary

Dublin, Ohio-based Neoprobe is to inject a further $8.1m, raised from its latest round of financing, into late-stage clinical development of its radiopharmaceutical agent Lymphoseek. The product will be used for assessing the spread of breast cancer and melanoma to the lymphatic system. The funds will also be used to prepare for initial clinical studies of the investigational RIGScan CR gamma detection system and to complete the commercial launch of two blood flow measurement products, the Quantix/OR and the Quantix/ND, which is expected to take place in 2005.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060585

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel